Hemispherx BioPharma Inc. (HEB) Gained 5.14% or 0.01 To Price $0.3 On Friday


Hemispherx BioPharma Inc. (HEB) gained 5.14% or 0.01 to $0.3. It is about 254469 shares traded, which is 65.6% compare to the average total volume 387900. The market cap of HEB is $14.09 million. The year to date change is -10.78%. The 52 week price range is from $0.28 to $0.65. Price of HEB have changed -5.20% during last week. It have changed -6.90% over last month, -6.57% over last 3 months, -45.40% over last 6 months and -30.93% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for HEB is 0.31. It is 3.33% above current price. The 200-day Moving Averages for HEB is 0.37. It is 23.33% above current price. The 52-week High is 0.65. It is 116.67% from the current price. The 52-week Low is 0.28. It is -6.67% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of HEB is 1.12 on 2018-07-13. Short % to float is 1.07%. There are some statistics of HEB. It is has market cap $14.09 million. The share outstanding is 46.20 million. The average volume is 387900. The percent of top 15 Institution holding is 7.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of HEB is -64.73%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of HEB is -45.57%.


Tags:

Share this post